News

FluMist, a nasal spray flu vaccine made by AstraZeneca, is now available for at-home use through a service called FluMist ...
The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...
American Academy of Pediatrics updates immunization guidelines, and recommends COVID-19 vaccines for young children, ...
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
Recent developments in weight-loss treatments have impacted the market significantly. Viking Therapeutics' new pill showed ...
Robert Kennedy Jr. signs recommendation eliminating mercury-based thimerosal from influenza vaccines, fulfilling anti-vaccine advocacy despite FDA safety data.
Australian shares are set to open lower this morning after US stocks ended roughly flat overnight, as local traders await ...
Novavax, Inc. (NASDAQ:NVAX) is one of the 11 Best Short Squeeze Stocks to Buy Now. The company’s non-mRNA COVID-19 vaccine is ...
(Reuters) -Australian biotech firm CSL said on Tuesday it would spin off its influenza vaccine division and would cut up to 15% of its workforce as part of a strategic overhaul, sending its shares ...
The move comes amid falling immunisation rates in the United States, CSL's largest market, and the looming threat of U.S. tariffs on Australian pharmaceuticals. CSL plans to list CSL Seqirus by the ...
One pharmacist tells ABC11, they're already seeing people getting sick with the flu, and the traditional flu season starts in ...